Conditions: Migraine Disorders
Keywords: Long-term Safety Migraine Adolescent Migraine Headache sumatriptan succinate naproxen sodium
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 656
Healthy volunteers: no

Brief summary:
This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.

Detailed description:
This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents (aged 12 to 17 years) for the acute treatment of migraine.

Arms:
arm 1: Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Interventions: intervention 1: Combination Tablet of Treximet (sumatriptan/naproxen sodium)
Intervention descriptions: intervention 1: Combination Tablet of Treximet(sumatriptan/naproxen sodium)

Protocol document: